Dr Ke is an employee of Pfizer Inc. All other authors have no conflict of interest.
Extracellular Nucleotides Act Through P2X7 Receptors to Activate NF-κB in Osteoclasts†
Version of Record online: 5 JAN 2004
Copyright © 2004 ASBMR
Journal of Bone and Mineral Research
Volume 19, Issue 4, pages 642–651, April 2004
How to Cite
Korcok, J., Raimundo, L. N., Ke, H. Z., Sims, S. M. and Dixon, S. J. (2004), Extracellular Nucleotides Act Through P2X7 Receptors to Activate NF-κB in Osteoclasts. J Bone Miner Res, 19: 642–651. doi: 10.1359/JBMR.040108
- Issue online: 2 DEC 2009
- Version of Record online: 5 JAN 2004
- Manuscript Accepted: 20 NOV 2003
- Manuscript Revised: 9 NOV 2003
- Manuscript Received: 11 SEP 2003
Nucleotides, released in response to mechanical and other stimuli, act on P2 receptors in osteoclasts and other cell types. In vitro studies of osteoclasts from rabbits and P2X7 receptor-deficient mice revealed that P2X7 receptors couple to activation of the key transcription factor NF-κB.
Introduction: Osteoclasts express functional P2X4 and P2X7 receptors, which are ATP-gated cation channels. Knockout (KO) of the P2X7 receptor has revealed its role in regulating bone formation and resorption, but the underlying signals are not known. The transcription factor NF-κB plays a key role in the response of osteoclasts to RANKL and other cytokines. The aim of this study was to examine whether P2X receptors on osteoclasts signal through NF-κB.
Materials and Methods: Osteoclasts were isolated from neonatal rabbits or wildtype (WT) and P2X7 receptor KO mice. Immunofluorescence was used to detect the p65 subunit of NF-κB, which, on activation, translocates from the cytosol to the nuclei. The concentration of cytosolic free Ca2+ ([Ca2+]i) was monitored in single osteoclasts loaded with fura-2.
Results: In control samples, few rabbit osteoclasts demonstrated nuclear localization of NF-κB. Benzoyl-benzoyl-ATP (BzATP, a P2X7 agonist, 300 μM) induced nuclear translocation of NF-κB after 3 h in ∼45% of rabbit osteoclasts. In contrast, a low concentration of ATP (10 μM, sufficient to activate P2X4 and P2Y2, but not P2X7 receptors) did not induce nuclear translocation of NF-κB. Because BzATP activates multiple P2 receptors, we examined responses of osteoclasts derived from WT and P2X7 receptor KO mice. Treatment with BzATP for 30 minutes increased nuclear localization of NF-κB in osteoclasts from WT but not KO mice, showing involvement of P2X7 receptors. Both ATP (10 μM) and BzATP (300 μM) caused transient elevation of [Ca2+]i, indicating that rise of calcium alone is not sufficient to activate NF-κB. Pretreatment of rabbit osteoclasts with osteoprotegerin inhibited translocation of NF-κB induced by RANKL but not by BzATP, establishing that the effects of BzATP are independent of RANKL signaling.
Conclusion: These findings show that P2X7 nucleotide receptors couple to activation of NF-κB in osteoclasts. Thus, nucleotides, released at sites of inflammation or in response to mechanical stimuli, may act through NF-κB to regulate osteoclast formation and activity.